China Malaria Drugs Market Research Report 2018

February 2018 | 101 pages | ID: CEDEE1C53B7EN
QYResearch

Abstracts

The global Malaria Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Malaria Drugs development status and future trend in China, focuses on top players in China, also splits Malaria Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma
• Kunming Pharmaceutical

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

On the basis of the end users/application, this report covers

• Prevention
• Treatment
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Malaria Drugs Market Research Report 2018

1 MALARIA DRUGS OVERVIEW

1.1 Product Overview and Scope of Malaria Drugs
1.2 Classification of Malaria Drugs by Product Category
  1.2.1 China Malaria Drugs Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China Malaria Drugs Sales (K Units) Market Share by Type in 2017
  1.2.3 Aryl Aminoalcohol Compounds
  1.2.4 Antifolate Compounds
  1.2.5 Artemisinin Compounds
1.3 China Malaria Drugs Market by Application/End Users
  1.3.1 China Malaria Drugs Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Prevention
  1.3.3 Treatment
  1.3.4 Other
1.4 China Malaria Drugs Market by Region
  1.4.1 China Malaria Drugs Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Malaria Drugs Status and Prospect (2013-2025)
  1.4.3 East China Malaria Drugs Status and Prospect (2013-2025)
  1.4.4 Southwest China Malaria Drugs Status and Prospect (2013-2025)
  1.4.5 Northeast China Malaria Drugs Status and Prospect (2013-2025)
  1.4.6 North China Malaria Drugs Status and Prospect (2013-2025)
  1.4.7 Central China Malaria Drugs Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Malaria Drugs (2013-2025)
  1.5.1 China Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China Malaria Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA MALARIA DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Malaria Drugs Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Malaria Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Malaria Drugs Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Malaria Drugs Market Competitive Situation and Trends
  2.4.1 China Malaria Drugs Market Concentration Rate
  2.4.2 China Malaria Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Malaria Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA MALARIA DRUGS SALES AND REVENUE BY REGION (2013-2018)

3.1 China Malaria Drugs Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Malaria Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Malaria Drugs Price (USD/Unit) by Regions (2013-2018)

4 CHINA MALARIA DRUGS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Malaria Drugs Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Malaria Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Malaria Drugs Price (USD/Unit) by Type (2013-2018)
4.4 China Malaria Drugs Sales Growth Rate (%) by Type (2013-2018)

5 CHINA MALARIA DRUGS SALES BY APPLICATION (2013-2018)

5.1 China Malaria Drugs Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Malaria Drugs Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA MALARIA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Cipla
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Malaria Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cipla Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Guilin Pharmaceutical
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Malaria Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Guilin Pharmaceutical Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 IPCA Laboratories
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Malaria Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 IPCA Laboratories Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Malaria Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Mylan Labs
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Malaria Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Labs Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Malaria Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Novartis
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Malaria Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Sanofi Aventis
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Malaria Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi Aventis Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Ajanta Pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Malaria Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ajanta Pharma Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Kunming Pharmaceutical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Malaria Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Kunming Pharmaceutical Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.10.4 Main Business/Business Overview

7 MALARIA DRUGS MANUFACTURING COST ANALYSIS

7.1 Malaria Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Malaria Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Malaria Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Malaria Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA MALARIA DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Malaria Drugs Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Malaria Drugs Sales (K Units) Forecast by Type (2018-2025)
11.3 China Malaria Drugs Sales (K Units) Forecast by Application (2018-2025)
11.4 China Malaria Drugs Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Malaria Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Malaria Drugs Sales (K Units) by Application (2013-2025)
Figure Product Picture of Malaria Drugs
Table China Malaria Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Malaria Drugs Sales Volume Market Share by Types in 2017
Figure Aryl Aminoalcohol Compounds Product Picture
Figure Antifolate Compounds Product Picture
Figure Artemisinin Compounds Product Picture
Figure China Malaria Drugs Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Malaria Drugs by Application in 2017
Figure Prevention Examples
Table Key Downstream Customer in Prevention
Figure Treatment Examples
Table Key Downstream Customer in Treatment
Figure Other Examples
Table Key Downstream Customer in Other
Figure South China Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Malaria Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Malaria Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Malaria Drugs Sales of Key Players/Manufacturers (2013-2018)
Table China Malaria Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Malaria Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 China Malaria Drugs Sales Share (%) by Players/Manufacturers
Table China Malaria Drugs Revenue by Players/Manufacturers (2013-2018)
Table China Malaria Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Malaria Drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Malaria Drugs Revenue Market Share (%) by Players/Manufacturers
Table China Market Malaria Drugs Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Malaria Drugs Average Price of Key Players/Manufacturers in 2017
Figure China Malaria Drugs Market Share of Top 3 Players/Manufacturers
Figure China Malaria Drugs Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Malaria Drugs Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Malaria Drugs Product Category
Table China Malaria Drugs Sales (K Units) by Regions (2013-2018)
Table China Malaria Drugs Sales Share (%) by Regions (2013-2018)
Figure China Malaria Drugs Sales Share (%) by Regions (2013-2018)
Figure China Malaria Drugs Sales Market Share (%) by Regions in 2017
Table China Malaria Drugs Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Malaria Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Malaria Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Malaria Drugs Revenue Market Share (%) by Regions in 2017
Table China Malaria Drugs Price (USD/Unit) by Regions (2013-2018)
Table China Malaria Drugs Sales (K Units) by Type (2013-2018)
Table China Malaria Drugs Sales Share (%) by Type (2013-2018)
Figure China Malaria Drugs Sales Share (%) by Type (2013-2018)
Figure China Malaria Drugs Sales Market Share (%) by Type in 2017
Table China Malaria Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Malaria Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Malaria Drugs by Type (2013-2018)
Figure Revenue Market Share of Malaria Drugs by Type in 2017
Table China Malaria Drugs Price (USD/Unit) by Types (2013-2018)
Figure China Malaria Drugs Sales Growth Rate (%) by Type (2013-2018)
Table China Malaria Drugs Sales (K Units) by Applications (2013-2018)
Table China Malaria Drugs Sales Market Share (%) by Applications (2013-2018)
Figure China Malaria Drugs Sales Market Share (%) by Application (2013-2018)
Figure China Malaria Drugs Sales Market Share (%) by Application in 2017
Table China Malaria Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure China Malaria Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Cipla Malaria Drugs Basic Information List
Table Cipla Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Cipla Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Cipla Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure Cipla Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table Guilin Pharmaceutical Malaria Drugs Basic Information List
Table Guilin Pharmaceutical Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Guilin Pharmaceutical Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Guilin Pharmaceutical Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure Guilin Pharmaceutical Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table IPCA Laboratories Malaria Drugs Basic Information List
Table IPCA Laboratories Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure IPCA Laboratories Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure IPCA Laboratories Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure IPCA Laboratories Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table GlaxoSmithKline Malaria Drugs Basic Information List
Table GlaxoSmithKline Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure GlaxoSmithKline Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table Mylan Labs Malaria Drugs Basic Information List
Table Mylan Labs Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Mylan Labs Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Mylan Labs Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure Mylan Labs Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table Roche Malaria Drugs Basic Information List
Table Roche Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Roche Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Roche Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure Roche Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table Novartis Malaria Drugs Basic Information List
Table Novartis Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Novartis Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Novartis Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure Novartis Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table Sanofi Aventis Malaria Drugs Basic Information List
Table Sanofi Aventis Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sanofi Aventis Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sanofi Aventis Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure Sanofi Aventis Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table Ajanta Pharma Malaria Drugs Basic Information List
Table Ajanta Pharma Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Ajanta Pharma Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Ajanta Pharma Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure Ajanta Pharma Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table Kunming Pharmaceutical Malaria Drugs Basic Information List
Table Kunming Pharmaceutical Malaria Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Kunming Pharmaceutical Malaria Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Kunming Pharmaceutical Malaria Drugs Sales Market Share (%) in China (2013-2018)
Figure Kunming Pharmaceutical Malaria Drugs Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Malaria Drugs
Figure Manufacturing Process Analysis of Malaria Drugs
Figure Malaria Drugs Industrial Chain Analysis
Table Raw Materials Sources of Malaria Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Malaria Drugs
Table Distributors/Traders List
Figure China Malaria Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Malaria Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Malaria Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table China Malaria Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Malaria Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Malaria Drugs Sales Volume Market Share Forecast by Type in 2025
Table China Malaria Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure China Malaria Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Malaria Drugs Sales Volume Market Share Forecast by Application in 2025
Table China Malaria Drugs Sales (K Units) Forecast by Regions (2018-2025)
Table China Malaria Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Malaria Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Malaria Drugs Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources